Vasculitis in systemic lupus erythematosis

被引:63
作者
Calamia, KT
Balabanova, M
机构
[1] Mayo Clin, Div Rheumatol, Jacksonville, FL 32224 USA
[2] Sofia Fac Med, Dept Dermatol, Sofia, Bulgaria
关键词
D O I
10.1016/j.clindermatol.2003.12.022
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vasculitis in connective tissue diseases is not an uncommon complication. Vasculitis complicates both rheumatoid arthritis and systemic lupus erythematosis (SLE) in about 4% of cases.(1) Cutaneous lesions, representing small-vessel involvement, are most common; however, widespread, necrotizing visceral medium-and large-vessel involvement, mimicking primary vasculitic syndromes, may also occur. Connective tissue disease-associated vasculitis is separated from primary vasculitis syndromes in classification schemes. Granulomatous large-vessel disease does not occur in connective tissue diseases, suggesting a different pathogenesis.(2) In most disorders, the etiology of vascular inflammation in not completely understood, but basic pathogenic mechanisms can often be distinguished. The role of immune complexes in the inflammatory manifestations of SLE is recognized, and other pathogenic factors such as antineutrophil cytoplasmic antibodies, common in other vasculitides, are infrequent. A diverse spectrum of clinical features, due to inflammatory involvement of arterial and venous vessels of all sizes, characterize several connective tissue diseases including Behcet's disease and SLE. The recognition of disease manifestations due to vasculitis in these disorders has important implications for treatment and may be critical to reduce morbidity and mortality.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 114 条
[1]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[2]   Update:: Treatment of systemic lupus erythematosus [J].
Alarcón-Segovia, D .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (02) :219-222
[3]   ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS [J].
ALARCONSEGOVIA, D ;
DELEZE, M ;
ORIA, CV ;
SANCHEZGUERRERO, J ;
GOMEZPACHECO, L ;
CABIEDES, J ;
FERNANDEZ, L ;
DELEON, SP .
MEDICINE, 1989, 68 (06) :353-365
[4]   PRELIMINARY CLASSIFICATION CRITERIA FOR THE ANTIPHOSPHOLIPID SYNDROME WITHIN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALARCONSEGOVIA, D ;
PEREZVAZQUEZ, ME ;
VILLA, AR ;
DRENKARD, C ;
CABIEDES, J .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) :275-286
[5]  
ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P762
[6]  
ALARCONSEGOVIA D, 1988, J RHEUMATOL, V15, P890
[7]   PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS [J].
ALARCONSEVOGIA, D ;
OSMUNDSON, PJ .
ANNALS OF INTERNAL MEDICINE, 1965, 62 (05) :907-+
[8]  
BACON PA, 1995, RHEUM DIS CLIN N AM, V21, P1077
[9]   Pathology and pathogenesis of vascular injury in systemic lupus erythematosus - Interactions of inflammatory cells and activated endothelium [J].
Belmont, HM ;
Abramson, SB ;
Lie, JT .
ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :9-22
[10]   Cutaneous vasculitis in children and adults -: Associated diseases and etiologic factors in 303 patients [J].
Blanco, R ;
Martínez-Taboada, VM ;
Rodríguez-Valverde, V ;
García-Fuentes, M .
MEDICINE, 1998, 77 (06) :403-418